Seidenberg Beth C's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Sep 20, 2024
- Accession no.
- 0001415889-24-023779
- Filed
- Sep 20, 2024
- Trade date
- Sep 18-19, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $696.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seidenberg Beth CCIK 0001184592 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2024 | Class A Common Stock | SSaleDisposed | −1,177 | $42.01 | −$49,445.77 | 160,376 | Direct | |
| Sep 18, 2024 | Class A Common Stock | SSaleDisposed | −1,476 | $42.00 | −$61,992 | 4,012 | Indirect | |
| Sep 19, 2024 | Class A Common Stock | SSaleDisposed | −13,823 | $42.31 | −$584,851.13 | 146,553 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.